4-Methylisoquinoline-5-sulfonyl chloride → HCID 70275386, Verbindung
Reaktionsgleichung
C(OC([N:8]1[CH2:13][C@H:12]([CH3:14])[NH:11][CH2:10][C@@H:9]1[CH3:15])=O)(C)(C)C.[Cl:16][S:17]([C:20]1[CH:29]=[CH:28][CH:27]=[C:26]2[C:21]=1[C:22]([CH3:30])=[CH:23][N:24]=[CH:25]2)(=[O:19])=[O:18]>>[ClH:16].[ClH:16].[CH3:15][C@H:9]1[CH2:10][NH:11][C@@H:12]([CH3:14])[CH2:13][N:8]1[S:17]([C:20]1[CH:29]=[CH:28][CH:27]=[C:26]2[C:21]=1[C:22]([CH3:30])=[CH:23][N:24]=[CH:25]2)(=[O:18])=[O:19]Komponenten
3
Versuchsvorschrift
Using 0.43 g of cis-1-(tert-butoxycarbonyl)-2,5-dimethylpiperazine and 0.48 g of 5-chlorosulfonyl-4-methylisoquinoline, the procedure of Example 1 was otherwise repeated to provide 0.2 g of the objective compound (white crystals).
Quellen und Nachweise
- ORD-Eintrag
- ord-9de509a29d4f4a9bb5a050d09dabb6d3
- Quelldatensatz
- uspto-grants-2000_11
- Patentnummer
- US06153608
Notizen zur Reaktion
Wird geladen…